Riham Idris

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 18, 2022
Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy.

Laura Schäkel, Salahuddin Mirza, Riekje Winzer

Pageof 1

Frequent Collaborators

1 joint publications

Laura Schäkel

1 joint publications

Salahuddin Mirza

1 joint publications

Riekje Winzer

1 joint publications

Vittoria Lopez